Antitumor Mechanism of Hydroxycamptothecin via the Metabolic Perturbation of Ribonucleotide and Deoxyribonucleotide in Human Colorectal Carcinoma Cells
Hydroxycamptothecin (SN38) is a natural plant extract isolated from <i>Camptotheca acuminate</i>. It has a broad spectrum of anticancer activity through inhibition of DNA topoisomerase I, which could affect DNA synthesis and lead to DNA damage. Thus, the action of SN38 against cancers co...
Main Authors: | Yan Li, Wendi Luo, Huixia Zhang, Caiyun Wang, Caiyuan Yu, Zhihong Jiang, Wei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/16/4902 |
Similar Items
-
Characterisation of an Escherichia coli line that completely lacks ribonucleotide reduction yields insights into the evolution of parasitism and endosymbiosis
by: Samantha DM Arras, et al.
Published: (2023-04-01) -
Advances in Antitumor Nano-Drug Delivery Systems of 10-Hydroxycamptothecin
by: Chen Y, et al.
Published: (2022-09-01) -
Clinical Study of Combining Chemotherapy of Oxaliplatin or 5-Fluorouracil/Leucovorin with Hydroxycamptothecine for Advanced Colorectal Cancer
by: Yuanjue SUN, et al.
Published: (2009-04-01) -
Mitochondrial-Targeted Triphenylphosphonium–Hydroxycamptothecin Conjugate and Its Nano-Formulations for Breast Cancer Therapy: In Vitro and In Vivo Investigation
by: Kunfeng Zhang, et al.
Published: (2023-01-01) -
Development of 10-Hydroxycamptothecin-crizotinib conjugate based on the synergistic effect on lung cancer cells
by: Zhen Liu, et al.
Published: (2023-12-01)